AAAmal A. Abbas

Amal A. Abbas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amal A. Abbas has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Doaa Zakaria

    Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Abbassia Square, P.O. Box 11566, Cairo, Egypt

    1 shared publication
  • Hala Ghareeb

    Clinical Pathology Department, Faculty of Medicine, Ain Shams University, Abbassia Square, P.O. Box 11566, Cairo, Egypt

    1 shared publication
  • Mai Mohammed

    Clinical Pathology Department, Faculty of Medicine, Ain Shams University, Abbassia Square, P.O. Box 11566, Cairo, Egypt

    1 shared publication
  • Randa Reda

    Clinical Pathology Department, Faculty of Medicine, Ain Shams University, Abbassia Square, P.O. Box 11566, Cairo, Egypt

    1 shared publication
  • Rania Ahmed Abo-Shady

    Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    1 shared publication
  • Rania H. El Kabarity

    Clinical Pathology Department, Faculty of Medicine, Ain Shams University, Abbassia Square, P.O. Box 11566, Cairo, Egypt

    1 shared publication

Latest Publications

  • Open Access

    The Interplay between Zinc, Vitamin D and, IL-17 in Patients with Chronic Hepatitis C Liver Disease

    by Randa Reda, Amal A. Abbas, Mai Mohammed, Shahira F. El Fedawy, Hala Ghareeb, Rania H. El Kabarity, Rania A. Abo-Shady, Doaa Zakaria

    Objectives. To assess zinc (Zn) and vitamin D (Vit. D) status in chronic Hepatitis C virus- (HCV) infected patients and their relationship to interleukin- (IL-) 17 and disease severity and then investigate whether Zn and Vit. D3 modulate IL-17 expression in chronic HCV patients.Methods. Seventy patients and fifty healthy subjects were investigated. Serum levels of Zn, Vit. D, and IL-17 were assessed in the patients group and subgroups. Patients lymphocytes were activatedin vitroin the presence or absence of Zn or Vit. D3 and then intracellular IL-17 production was assessed using flow cytometry.Results. Zn and Vit. D were significantly decreased in HCV patients. Increasing disease severity leads to more reduction in Zn level opposed by increasing IL-17 level. Zn potently reduced IL-17 production in a dose-related fashion; however it did not exert any toxic effects. Although Vit. D apparently increases IL17 expression, it is unclear whether it is due to its toxic effect on cell count or lack of definite association between Vit. D and both IL-17 and disease severity.Conclusions. This study demonstrates that Zn modulates IL-17 expression and provides a rationale for evaluating this compound as a supplementary agent in the treatment of chronic HCV.